Back to MW MARSHALL WACE, LLP

ABCLABCL
15 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ABCELLERA BIOLOGICS INC

MARSHALL WACE, LLP holds 1.9M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $14.9M as of 2026-Q2. The position was increased (+428.9% shares). ABCL represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$14.9M

Current Shares

1.9M

Total Value Change

-$5.7M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+428.9%
$14.9M0.0%$7.85
45
2026-Q1
New
359,683
-
$1.3M0.0%$3.71
35
2025-Q4
Exited
0
-100.0%
$00.0%$3.45
0
2025-Q3
Unchanged
47,480
0.0%
$238,8240.0%$4.87
0
2025-Q2
Unchanged
47,480
0.0%
$162,8560.0%$3.61
0
2025-Q1
New
47,480
-
$105,8800.0%$2.31
30
2023-Q1
Exited
0
-100.0%
$00.0%$7.42
0
2022-Q4
Decreased
97,600
-72.5%
$988,6890.0%$10.13
0
2022-Q3
Decreased
354,397
-31.0%
$3.5M0.0%$9.85
0
2022-Q2
New
513,710
-
$5.5M0.0%$10.11
37
2021-Q4
Exited
0
-100.0%
$00.0%$14.34
0
2021-Q3
Increased
338,120
+23.7%
$6.8M0.0%$19.45
33
2021-Q2
Increased
273,279
+439.6%
$6M0.0%$21.28
44
2021-Q1
Decreased
50,641
-90.1%
$1.7M0.0%$26.68
0
2020-Q4
New
512,410
-
$20.6M0.1%$41.10
47

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used